In previous reports (Elberg and Herzberg, 1953; Herzberg and Elberg, 1953) the isolation and characteristics of a streptomycin-dependent mutant of Brucella melitenis were described.2 The streptomycin-dependent strain retained the biochemical and antigenic characteristics of the virulent parent strain but differed in a require-ment for streptomycin for its growth. Growth in vivo was not influenced detectably by in vivo administration of streptomycin. The following studies describe the capabilities of this strain for inducing protection of mice and guinea pigs against experimental infection with virulent B. melitensis. MATERIALS AND METHODS These were described in considerable detail in the first paper of the series (Herzberg and Elberg, 1953...
Typescript (photocopy).Mice were infected with a non-lethal strain of Babesia microti and challenged...
The lipopolysaccharide (LPS) is considered the major virulent factor in Brucella spp. Several genes ...
Mice passively immunized prior to a challenge infection with immunoglobulin G (IgG) and IgM monoclon...
Vaccination of BALB/c mice with live Brucella abortus RB51, a stable rough mutant, produced protecti...
Objective - To evaluate stable rough mutants derived from Brucella melitensis 16M and B suis 2579 (b...
Human brucellosis can be acquired from infected animal tissues by ingestion, inhalation, or contamin...
Summary. Following incubation of the oral vaccine Brucella suis strain 2 with diethyl sulphate (DES)...
BALB/c mice were immunized with recombinant Escherichia coli expressing the omp31 gene of Brucella m...
C57Bl/10 mice have a superior ability to control chronic infections with virulent strains of the int...
Aim: The major objective of the investigation was to evaluate the hitherto uncharacterized potential...
Mice were vaccinated with the indicated strains or inoculated with saline alone were challenged with...
In BALB/c mice infected i.v. with attenuated strain 19 of Brucella abortus, the organism replicates ...
Des souris sont immunisées par une injection sous-cutanée de 10“ Brucella abortus inactivées par la ...
All smooth strains of Brucella bear two lipopolysaccharide (LPS) antigens in a ratio that defines th...
A total of 171 cultures of Brucella, mostly isolated in this country from milk and foetal material, ...
Typescript (photocopy).Mice were infected with a non-lethal strain of Babesia microti and challenged...
The lipopolysaccharide (LPS) is considered the major virulent factor in Brucella spp. Several genes ...
Mice passively immunized prior to a challenge infection with immunoglobulin G (IgG) and IgM monoclon...
Vaccination of BALB/c mice with live Brucella abortus RB51, a stable rough mutant, produced protecti...
Objective - To evaluate stable rough mutants derived from Brucella melitensis 16M and B suis 2579 (b...
Human brucellosis can be acquired from infected animal tissues by ingestion, inhalation, or contamin...
Summary. Following incubation of the oral vaccine Brucella suis strain 2 with diethyl sulphate (DES)...
BALB/c mice were immunized with recombinant Escherichia coli expressing the omp31 gene of Brucella m...
C57Bl/10 mice have a superior ability to control chronic infections with virulent strains of the int...
Aim: The major objective of the investigation was to evaluate the hitherto uncharacterized potential...
Mice were vaccinated with the indicated strains or inoculated with saline alone were challenged with...
In BALB/c mice infected i.v. with attenuated strain 19 of Brucella abortus, the organism replicates ...
Des souris sont immunisées par une injection sous-cutanée de 10“ Brucella abortus inactivées par la ...
All smooth strains of Brucella bear two lipopolysaccharide (LPS) antigens in a ratio that defines th...
A total of 171 cultures of Brucella, mostly isolated in this country from milk and foetal material, ...
Typescript (photocopy).Mice were infected with a non-lethal strain of Babesia microti and challenged...
The lipopolysaccharide (LPS) is considered the major virulent factor in Brucella spp. Several genes ...
Mice passively immunized prior to a challenge infection with immunoglobulin G (IgG) and IgM monoclon...